HSDT — Helius Medical Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $2.15m
- -$1.49m
- $0.64m
Annual cashflow statement for Helius Medical Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | — | — |
| Source: | 10-K | 10-K | 10-K | ||
| Standards: | USG | USG | USG | — | — |
| Status: | Final | Final | Final | fx Preliminary | fx Preliminary |
| Net Income/Starting Line | -9.78 | -14.1 | -18.1 | — | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -9.13 | 2.93 | 4.3 | — | — |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2.28 | -1.02 | 0.127 | — | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -21 | -11.7 | -13.4 | — | — |
| Capital Expenditures | -0.353 | -0.07 | -0.056 | — | — |
| Purchase of Fixed Assets | |||||
| Software Development Costs | |||||
| Other Investing Cash Flow Items | -0.416 | 0.061 | 0 | — | — |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.769 | -0.009 | -0.056 | — | — |
| Financing Cash Flow Items | -0.247 | -1.01 | -2.89 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.65 | 9.64 | 21.1 | — | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -20.1 | -2.13 | 7.67 | — | — |